P&G stock price today: Procter & Gamble edges higher as shutdown clouds key data

P&G stock price today: Procter & Gamble edges higher as shutdown clouds key data

New York, Feb 2, 2026, 14:18 EST — Regular session

  • P&G shares climbed in afternoon trading, following gains across the consumer-staples sector
  • The January jobs report was postponed due to a partial U.S. government shutdown, injecting uncertainty into the week’s data schedule
  • Investors are focused on upcoming funding decisions in Washington and P&G’s dividend payout scheduled for Feb. 17

Procter & Gamble shares edged up roughly 0.7% to $152.82 in afternoon trading Monday, fluctuating between $151.37 and $153.21. The Consumer Staples Select Sector SPDR Fund climbed about 1%. Colgate-Palmolive and Church & Dwight saw gains, while Kimberly-Clark dipped. Unilever’s stock remained mostly flat.

This move is significant because major consumer staples stocks have turned into a safe haven whenever macro headlines get tangled. Traders face a week loaded with earnings and economic data, yet one crucial indicator has abruptly vanished.

Procter & Gamble’s stock often serves as a quick test of its pricing power. When investors believe consumers will continue paying up for branded essentials, they’re usually willing to accept slower volume growth and view the shares as a steadying force.

The broader market recovered from early losses sparked by a steep fall in precious metals, as tech and memory stocks pushed major indexes up, Reuters reported. “We’re heading into a new week with plenty of catalysts in front of us,” said Art Hogan of B. Riley Wealth. (Reuters)

New data stirred the mix. The Institute for Supply Management reported its Purchasing Managers’ Index (PMI) climbed to 52.6 in January, marking the first expansion in 12 months, boosted by a surge in new orders. Susan Spence noted, “some buying appears to be to get ahead of expected price increases due to ongoing tariff issues.” (Reuters)

Then came a curveball. The U.S. Bureau of Labor Statistics announced the January employment report won’t drop on Friday due to the partial government shutdown that started Saturday. “The release will be rescheduled upon the resumption of government funding,” said Emily Liddel. House lawmakers are expected to vote on funding by Tuesday, Reuters reports. (Reuters)

The company’s last major trigger was its Jan. 22 earnings report. Procter & Gamble posted revenue just below forecasts as U.S. consumer spending cooled, though core earnings per share — which exclude certain one-off items — surpassed estimates. The firm held firm on its full-year sales and core profit guidance. “We need to get the U.S. growing,” Andre Schulten told analysts. (Reuters)

Dividend investors eye a key date coming up soon. Procter & Gamble’s most recent quarterly dividend stands at $1.0568 per share, scheduled for payment on Feb. 17. The stock went ex-dividend on Jan. 23, according to the company’s dividend history. (P&G Investor)

That “defensive” trade can flip just as fast. If risk appetite holds, funds might shift out of staples in a hurry. P&G faces the challenge of boosting volumes without relying too much on price hikes, particularly since tariffs and input costs remain a wildcard for margins.

Traders now eye Tuesday’s House vote on restoring government funding and look for any update on the postponed jobs report’s new date. For P&G investors, the closest company event is the Feb. 17 dividend payout.

Stock Market Today

  • TSX Penny Stocks Spotlight: Automotive Finco and Top Picks Amid Solid Market Start
    February 2, 2026, 2:49 PM EST. The TSX begins Q4 earnings season with solid momentum, highlighting penny stocks as potential opportunities for investors. Automotive Finco Corp., with a CA$26.16 million market cap, stands out for its debt-free status and steady earnings, though its high 15.55% dividend yield raises sustainability concerns. Aurora Spine Corporation, valued at CA$24.4 million, focuses on innovative spinal devices but struggles financially. Other notable TSX penny stocks include Westbridge Renewable Energy, Cannara Biotech, and Zoomd Technologies, each showing strong financial health ratings, making them intriguing targets for those seeking affordable growth plays within the Canadian market.
PepsiCo stock price climbs as PEP traders brace for Tuesday earnings and 2026 outlook
Previous Story

PepsiCo stock price climbs as PEP traders brace for Tuesday earnings and 2026 outlook

Uber stock price rises as France driver status dispute adds fresh risk ahead of earnings
Next Story

Uber stock price rises as France driver status dispute adds fresh risk ahead of earnings

Go toTop